Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2005
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732
Harvey B Niell, James E Herndon, Antonius A Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M Strauss, James E Herndon, Michael A Maddaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer
Caio Max S Rocha Lima, Diane Savarese, Howard Bruckner, et al.
Lancet (London, England)
|
July 28, 2009
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S Albain, R Suzanne Swann, Valerie W Rusch, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2005
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732
Harvey B Niell, James E Herndon, Antonius A Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M Strauss, James E Herndon, Michael A Maddaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer
Caio Max S Rocha Lima, Diane Savarese, Howard Bruckner, et al.
Lancet (London, England)
|
July 28, 2009
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S Albain, R Suzanne Swann, Valerie W Rusch, et al.
Page
of 7